EcoR1 Capital
Highly Engaged Employees
Highly Engaged EmployeesFinance · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
357 Tehama St Ste 3, San Francisco, Cali...Phone Number
(415) 754-3517Website
www.ecor1cap.comRevenue
<$5 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
2
About EcoR1 Capital
EcoR1 Capital is a San Francisco-based investment fund focused on the biotech sector. The company aims to build long-term partnerships with innovative entrepreneurs dedicated to advancing therapeutic innovation and developing new medicines. Their venture portfolio is centered around supporting breakthroughs in biological and chemical discovery, leveraging a deep understanding of the molecular basis of disease. EcoR1 Capital is committed to fostering an environment where innovation thrives and scientific curiosity is encouraged.Explore more
EcoR1 Capital Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is EcoR1 Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if EcoR1 Capital had a recent Job posting/layoffs
Check out if EcoR1 Capital is spiking on competitors!
Earning: See what the market has to say on EcoR1 Capital recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once EcoR1 Capital has new funding data
Product Launch: Get notified when EcoR1 Capital launches new products
Check if EcoR1 Capital has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
EcoR1 Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at EcoR1 Capital
Recommended Actions
Find VP level buyers at EcoR1 Capital
Find 3 more new buyers
Compare Similar Companies to EcoR1 Capital
Compare insights from companies similar to EcoR1 Capital, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
EcoR1 Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
EcoR1 Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about EcoR1 Capital.
EcoR1 Capital Tech Stack
A closer look at the technologies used by EcoR1 Capital
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
EcoR1 Capital News & Media
EcoR1 Capital, LLC Increases Stake in Zymeworks Inc - GuruFocus
On January 2, 2025, EcoR1 Capital, LLC (Trades, Portfolio) executed a notable transaction involving Zymeworks Inc. The firm added 363,369 shares of Zymeworks InEcor1 capital increases stake in Zymeworks with $1.88 million purchase - Investing.com
Ecor1 capital increases stake in Zymeworks with $1.88 million purchaseAjax Therapeutics Raises $95M in Series C Financing
Ajax Therapeutics, a NYC- snd Cambridge, MA-based biopharmaceutical company developing JAK inhibitors for patients with myeloproliferative neoplasms (MPNs), raised $95M in Series C funding. The round was led by Goldman Sachs Alternatives with participation by Eli Lilly and Company, Vivo Capital, RA Capital Management, Point72 and existing investors EcoR1 Capital, Boxer Capital, Schrödinger, Inc. and […] The post Ajax Therapeutics Raises $95M in Series C Financing appeared first on FinSMEs.
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding EcoR1 Capital
Sign Up For FreeTo access detailed company insights
EcoR1 Capital is a San Francisco-based investment fund focused on the biotech sector. The company aims to build long-term partnerships with innovative entrepreneurs dedicated to advancing therapeutic innovation and developing new medicines. Their venture portfolio is centered around supporting breakthroughs in biological and chemical discovery, lev... Read More
